INFLAMMATORY CYTOKINE ANALYSIS AND EARLY DETECTION OF RENAL DYSFUNCTION IN COVID-19 PATIENTS WITHOUT COMORBID STATES
Keywords:
COVID-19, interleukin-6, collagen IV, nephrinuria, creatinine, cystatin C, estimated glomerular filtration rateAbstract
The article assessed and compared the glomerular filtration rate using creatinine and cystatin C in patients with renal dysfunction without comorbidities who had COVID-19. The results showed the reliability of cystatin C compared to creatinine in identifying latent renal failure with latent renal dysfunction. Correlation analysis confirmed the high significance of nephrinuria and interleukin-6 in the development of chronic kidney disease.
References
Грановская М.В., Заславская К.Я. COVID-19 – набор симптомов или системная патология? Клиническая лекция. Часть 1. Особенности полиорганных нарушений // Инфекционные болезни: новости, мнения, обучение. 2020. Т. 9, № 3. Приложение. С. 3–9. DOI: https://doi.org/10.33029/2305-3496-2020-9-3S-3-9
Н.Г.Кульченко. Эпидемиология болезней почек у пациентов с covid-19. Исследования и практика в медицине 2020, т.7, №3, с. 74-82 Обзор https://doi.org/10.17709/2409-2231-2020-7-3-7.;
Ackermann M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 2020; 383: 120–8. DOI: https://doi.org/10.1056/NEJMoa2015432
Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, Lartey S, Onyango TB, Kuwelker K, Sævik M, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607–1613. doi: 10.1038/s41591-021-01433-3.
Fagone P., Ciurleo R., Lombardo S.D., Iacobello C., et al. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specifi c differences and predicts tailored therapeutic strategies. Autoimmun Rev. 2020; 19 (7): 102571. DOI: https://doi.org/10.1016/j.autrev.2020.102571
Giacosa A, Barrile GC, Gasparri C, Perna S, Rondanelli M. Positive Effect of Lecithin-Based Delivery Form of Curcuma and Boswellia Extracts on Irritable Bowel Syndrome After COVID-19 Infection. Nutrients. 2025 Feb 18;17(4):723. doi: 10.3390/nu17040723. PMID: 40005051; PMCID: PMC11858738.,
Hurme A, Viinanen A, Teräsjärvi J, Jalkanen P, Feuth T, Löyttyniemi E, Vuorinen T, Kantele A, Oksi J, He Q, Julkunen I. Post-COVID-19 condition in prospective inpatient and outpatient cohorts. Sci Rep. 2025 Feb 26;15(1):6925. doi: 10.1038/s41598-025-90819-1. PMID: 40011519.
Kuba K., Imai Y., Ohto-Nakanishi T., Penninger J.M. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 2010: 128 (1): 119–28. DOI: https://doi.org/10.1016/j.pharmthera.2010.06.003 69.
Lax S.F., Skok K., Zechner P., et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series. Ann Intern Med. 2020;173 (5): 350–61. DOI: https://doi. org/10.7326/m20-2566
Marques da Silva B, Gameiro J, Lei Teixeira J, Costa C, Branco C, Oliveira J, Bernardo J, Marques F, Agapito Fonseca J, Lopes JA. Long-term outcomes after AKI in hospitalized patients with COVID-19. Nefrologia (Engl Ed). 2025 Feb;45(2):150-158. doi: 10.1016/j.nefroe.2025.01.009. PMID: 39986713.,
Stefania MN, Toma C, Bondor CI, Maria RV, Florin P, Adina MM. Long COVID and Lung Involvement: A One-Year Longitudinal, Real-Life Study. Medicina (Kaunas). 2025 Feb 10;61(2):304. doi: 10.3390/medicina61020304. PMID: 40005421; PMCID: PMC11857727.
Su H., Yang M., Wan C., Yi L.X., et al. Renal histopathological analysis of 26 postmortem fi ndings of pa tients with COVID-19 in China. Kidney Int. 2020; 98 (1): 219–27. DOI: https://doi.org/https://doi.org/10.1016/j. kint.2020.04.003
Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18 (4): 844–7. DOI: https://doi.org/10.1111/ jth.14768
Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 2022;13:1812. doi: 10.1038/s41467-022-29513-z.// Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2022;324:603–605. doi: 10.1001/jama.2020.12603.
Vaduganathan M., Vardeny O., Michel T., McMurray J.J.V., et al. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020; 382 (17): 1653–9. DOI: https://doi.org/10.1056/NEJMsr2005760
van de Veerdonk F., Netea M.G., van Deuren M., et al. Kinins and cytokines in COVID-19: a comprehensive pathophysiological approach. Preprints 2020. 2020040023. DOI: https://doi.org/10.20944/preprints202004.0023.v1
World Health Organization (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus. https://www.who.int/publications-detail-redirect,
Xiaoming Wu. And others. Damage to endothelial barriers and its contribution to long COVID Angiogenesis. 2024 Feb;27(1):5-22. doi: 10.1007/s10456-023-09878-5. Epub 2023 Apr 27.
